BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 36765485)

  • 1. [Clinical Analysis of Pulmonary Lymphoma].
    Li L; Han Q; Gu Y; Ge Z
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2023 Feb; 31(1):109-114. PubMed ID: 36765485
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [A clinical analysis of 40 cases of primary and secondary pulmonary lymphoma].
    Niu X; Hu H; Gao J; Nie Y; Zhao W; Xu H; Bai X; Chen L
    Zhonghua Jie He He Hu Xi Za Zhi; 2014 Jul; 37(7):502-6. PubMed ID: 25262690
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of 18F-FDG PET/CT in patients affected by pulmonary primary lymphoma.
    Peng Y; Qi W; Luo Z; Zeng Q; Huang Y; Wang Y; Sharma A; Schmidt-Wolf IGH; Liao F
    Front Oncol; 2022; 12():973109. PubMed ID: 36185301
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical features and outcomes of pulmonary lymphoma: A single center experience of 180 cases.
    Zhang MC; Zhou M; Song Q; Wang S; Shi Q; Wang L; Yan FH; Qu JM; Zhao WL
    Lung Cancer; 2019 Jun; 132():39-44. PubMed ID: 31097092
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of radiologic characteristics and pathological presentations of primary pulmonary lymphoma in 22 patients.
    Wang Y; Han J; Zhang F; Wang Z; Zhao D; Wang X; Wu N; Lu R; Wu C; Gao J; Pan L; Xue X
    J Int Med Res; 2020 Apr; 48(4):300060519879854. PubMed ID: 31880183
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Correlation between
    Zhao J; Wang H
    J Med Imaging Radiat Oncol; 2021 Apr; 65(2):188-194. PubMed ID: 33538120
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pulmonary mucosa-associated lymphoid tissue lymphoma:
    Albano D; Borghesi A; Bosio G; Bertoli M; Maroldi R; Giubbini R; Bertagna F
    Br J Radiol; 2017 Nov; 90(1079):20170311. PubMed ID: 28830222
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Prognostic value of pretreatment (18)F-FDG PET-CT for patients with advanced diffuse large B-cell lymphoma].
    Ding CY; Guo Z; Sun J; Yang WP; Li TR
    Zhonghua Zhong Liu Za Zhi; 2018 Jul; 40(7):528-533. PubMed ID: 30060362
    [No Abstract]   [Full Text] [Related]  

  • 9. [Pulmonary mucosa-associated lymphoid tissue lymphoma concurrent with lung squamous cell carcinoma: a case report and literature review].
    Zhang CS; Yang XR; Ding W; Lu XY; Shen L; Zhao YF
    Zhonghua Jie He He Hu Xi Za Zhi; 2020 Dec; 43(12):1071-1076. PubMed ID: 33333642
    [No Abstract]   [Full Text] [Related]  

  • 10. HRCT in primary pulmonary lymphoma: can CT imaging phenotypes differentiate histological subtypes between mucosa-associated lymphoid tissue (MALT) lymphoma and non-MALT lymphoma?
    Chen Y; Chen A; Jiang H; Zhang Y; Zhu L; Xia C; Yu H
    J Thorac Dis; 2018 Nov; 10(11):6040-6049. PubMed ID: 30622775
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prognostic role of baseline
    Albano D; Bosio G; Camoni L; Farina M; Re A; Tucci A; Giubbini R; Bertagna F
    Hematol Oncol; 2019 Feb; 37(1):39-46. PubMed ID: 30299563
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Significance of imaging and clinical features in the differentiation between primary and secondary pulmonary lymphoma.
    Dong Y; Zeng M; Zhang B; Han L; Liu E; Lian Z; Liu J; Liang C; Zhang S
    Oncol Lett; 2017 Nov; 14(5):6224-6230. PubMed ID: 29113271
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of the prognostic values of
    Lim CH; Hyun SH; Moon SH; Cho YS; Choi JY; Lee KH
    Sci Rep; 2020 Jul; 10(1):12748. PubMed ID: 32728134
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognostic superiority of the National Comprehensive Cancer Network International Prognostic Index over pretreatment whole-body volumetric-metabolic FDG-PET/CT metrics in diffuse large B-cell lymphoma.
    Adams HJ; de Klerk JM; Fijnheer R; Heggelman BG; Dubois SV; Nievelstein RA; Kwee TC
    Eur J Haematol; 2015 Jun; 94(6):532-9. PubMed ID: 25311082
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Functional Parameters of
    Yang J; Zhu S; Pang F; Xu M; Dong Y; Hao J; Ma X
    Contrast Media Mol Imaging; 2018; 2018():8659826. PubMed ID: 30363729
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical Analysis of 50 Cases of Primary Pulmonary Lymphoma: A Retrospective Study and Literature Review.
    Hu M; Gu W; Chen S; Mei J; Wang W
    Technol Cancer Res Treat; 2022; 21():15330338221075529. PubMed ID: 35253550
    [No Abstract]   [Full Text] [Related]  

  • 17. Clinical and misdiagnosed analysis of primary pulmonary lymphoma: a retrospective study.
    Yao D; Zhang L; Wu PL; Gu XL; Chen YF; Wang LX; Huang XY
    BMC Cancer; 2018 Mar; 18(1):281. PubMed ID: 29530011
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of the prognostic value of different methods of calculating the tumour metabolic volume with
    Guzmán Ortiz S; Mucientes Rasilla J; Vargas Núñez JA; Royuela A; Navarro Matilla B; Mitjavila Casanovas M
    Rev Esp Med Nucl Imagen Mol (Engl Ed); 2020; 39(6):340-346. PubMed ID: 32646783
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [(18)F-fluorodeoxy glucose positron emission tomography/computed tomography manifestation and clinical characteristics of primary salivary gland-type lung cancer].
    Ding CY; Li YY; Sun J; Guo Z; Li TR
    Zhonghua Zhong Liu Za Zhi; 2019 Apr; 41(4):288-293. PubMed ID: 31014054
    [No Abstract]   [Full Text] [Related]  

  • 20. Correlation study on 18F-FDG PET/CT metabolic characteristics of primary lesion with clinical stage in lung cancer.
    Hu WD; Wang HC; Wang YB; Cui LL; Chen XH
    Q J Nucl Med Mol Imaging; 2021 Jun; 65(2):172-177. PubMed ID: 30916535
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.